Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
08.05.24
/
50%
€0.36
Target price
08.05.25
€58.61
Performance (%)
-7.73%
Price
14:06
€0.33
Summary
This prediction is currently active. With a performance of -7.73%, the BUY prediction for Galmed Pharmaceuticals Ltd. by BTIG_Research is down slightly. This prediction currently runs until 08.05.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | 0.000% |
iShares Core DAX® | 0.597% |
iShares Nasdaq 100 | 0.899% |
iShares Nikkei 225® | 1.775% |
iShares S&P 500 | 0.990% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $60.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
0.60%
14:06
14:06
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
12.84%
14:06
14:06